Mastelli is an Italian biopharmaceutical company with a leading presence in the field of regenerative medicine since 1952. It was the first company to develop PN-HPT™ polynucleotides, backed by expertise and more than 100 scientific studies. With its patented HPT™ (Highly Purified Technology), Mastelli guarantees the purity, biocompatibility, and stability of its products, delivering predictable and safe results.
Plinest® and Newest® are the first and original PN-HPT™ polynucleotide formulas, offering personalized bio-regeneration solutions with clinically proven efficacy and a high safety profile.
Learn more about Mastelli Here.
